In select patients with small cell lung cancer (SCLC), stereotactic radiotherapy (SRS) might be a reasonable choice for control of brain metastases when compared with whole brain radiotherapy (WBRT), ...

May 1, 2012 (Miami, Florida) — For patients with brain metastases from non–small cell lung cancer (NSCLC), the risk for leukoencephalopathy was much lower if they were treated with stereotactic ...

Early patient data from Phase 2b clinical trial showed significant and selective tumor uptake in brain metastases compared to MRIPhase 2b ...

Optimizing infusion wait time: Redesigning medication order verification/approval at a comprehensive cancer center. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This abstract ...

Stereotactic radiosurgery (SRS) for brainstem metastases (BSM) appears to be safe and effective, and comparable to SRS for non-brainstem brain metastases (BM), according to researchers. Their ...

Stereotactic radiosurgery (SRS) sends narrow beams of radiation into your cancer. The beams can focus on a tumor of any size or shape. It causes little damage to nearby healthy cells. If you have only ...

Today, up to four million brain tumor patients globally lack access to what many consider a critical standard of care: stereotactic radiosurgery (SRS) – a completely non-invasive one-day outpatient ...

Theranostics announced that the Phase 2b trial evaluating RAD101 imaging in brain metastases has achieved 50% patient enrollment ...

After the 1990 study by Patchell, which established a survival benefit from resection of a single metastatic lesion to the brain beyond that of WBRT alone, the next logical question was whether or not ...

The UAB Department of Radiation Oncology has partnered with Varian to develop a three-day conference that discusses and demonstrates stereotactic radiation (SRS) and stereotactic body radiation (SBRT) ...